Lipopolysaccharide neutralization by a novel peptide derived from phosvitin

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 11, 2013, Pages 2622-2631

  Hu, Lili ^a   Sun, Chen ^a   Wang, Shengnan ^a   Su, Feng ^b   Zhang, Shicui ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antimicrobial peptide; Endotoxin; Lipopolysaccharide (LPS); Sepsis; Tumor necrosis factor (TNF)

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PHOSVITIN; PT5 PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PEPTIDE; PROTECTIVE AGENT; PROTEIN BINDING; RECOMBINANT PROTEIN; TEICHOIC ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; ENDOTOXEMIA; ESCHERICHIA COLI; LIVER INJURY; LIVER PROTECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SEPSIS; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; ZEBRA FISH; ANIMAL; BACTERIA; BIOSYNTHESIS; CELL DEATH; CELL LINE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; HUMAN; LIVER; METABOLISM; MICROBIAL SENSITIVITY TEST; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SERODIAGNOSIS; ULTRASTRUCTURE;

DANIO RERIO; ESCHERICHIA COLI; MURINAE; MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL DEATH; CELL LINE; CELL MEMBRANE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTOXEMIA; ERYTHROCYTES; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LIVER; MICE; MICROBIAL SENSITIVITY TESTS; NEUTRALIZATION TESTS; PEPTIDES; PHOSVITIN; PROTECTIVE AGENTS; PROTEIN BINDING; RECOMBINANT PROTEINS; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884494313     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.09.002     Document Type: Article

References (34)

1. B. Beutler, and A. Cerami Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation Immunol Res 5 1986 281 293 (Pubitemid 17059101)
2. R.C. Bone The pathogenesis of sepsis Ann Intern Med 115 1991 457 469
3. R.C. Bone, R.A. Balk, A.M. Fein, T.M. Perl, R.P. Wenzel, and H.D. Reines A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group Crit Care Med 23 1995 994 1006
4. C. Chen, R. Brock, F. Luh, P.J. Chou, J.W. Larrick, and R.F. Huang The solution structure of the active domain of CAP18 - a lipopolysaccharide binding protein from rabbit leukocytes FEBS Lett 370 1995 46 52
5. O. Cirioni, A. Giacometti, R. Ghiselli, C. Bergnach, F. Orlando, and C. Silvestri LL-37 protects rats against lethal sepsis caused by Gram-negative bacteria Antimicrob Agents Chemother 50 2006 1672 1679
6. Y. Ding, X. Liu, L. Bu, H. Li, and S. Zhang Antimicrobial- immunomodulatory activities of zebrafish phosvitin-derived peptide Pt5 Peptides 37 2012 309 313
7. R. Ghiselli, A. Giacometti, O. Cirioni, R. Circo, F. Mocchegiani, and B. Skerlavaj Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide Shock 19 2003 577 581
8. A. Giacometti, O. Cirioni, R. Ghiselli, C. Viticchi, F. Mocchegiani, and A. Riva Effect of mono-dose intraperitoneal cecropins in experimental septic shock Crit Care Med 29 2001 1666 1669 (Pubitemid 32848362)
9. M. Gilliet, and R. Lande Antimicrobial peptides and self-DNA in autoimmune skin inflammation Curr Opin Immunol 20 2008 401 407
10. C.E. Hack, L.A. Aarden, and L.G. Thijs Role of cytokines in sepsis Adv Immunol 66 1997 101 195 (Pubitemid 27430942)
11. J. Hernandez-Rodriguez, M. Segarra, C. Vilardell, M. Sanchez, A. Garcia-Martinez, and M.J. Esteban Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis Rheumatology (Oxford) 43 2004 294 301 (Pubitemid 38313176)
12. T. Itoh, Y. Abe, and S. Adachi Comparative Studies on the α and β-Phosvitin from Hen's Egg Yolk J Food Sci 48 1983 1755 1757
13. S.K. Leaver, S.J. Finney, A. Burke-Gaffney, and T.W. Evans Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities Crit Care Med 35 2007 1404 1410 (Pubitemid 46642673)
14. M. Liu, and S. Zhang A kringle-containing protease with plasminogen-like activity in the basal chordate Branchiostoma belcheri Bioscience Rep 29 2009 385 395
15. J. Ma, H. Wang, Y. Wang, and S. Zhang Endotoxin-neutralizing activity of hen egg phosvitin Mol Immunol 53 2013 355 362
16. T. Mayumi, J. Takezawa, H. Takahashi, N. Kuwayama, T. Fukuoka, and K. Shimizu Low-dose intramuscular polymyxin B improves survival of septic rats Shock 11 1999 82 86
17. N. Mookherjee, and R.E. Hancock Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections Cell Mol Life Sci 64 2007 922 933 (Pubitemid 46597762)
18. I. Nagaoka, S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, and H. Tamura Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells J Immunol 167 2001 3329 3338 (Pubitemid 32852575)
19. J.E. Parrillo Pathogenetic mechanisms of septic shock N Engl J Med 328 1993 1471 1477
20. L.A. Pirofski, and A. Casadevall Immunomodulators as an antimicrobial tool Curr Opin Microbiol 9 2006 489 495 (Pubitemid 44404173)
21. J.D. Ren, H.F. Gao, M. Tang, J.S. Gu, P.Y. Xia, and G.X. Xiao Lipopolysaccharide (LPS) detoxification of analogue peptides derived from limulus anti-LPS factor Peptides 31 2010 1853 1859
22. J.D. Ren, J.S. Gu, H.F. Gao, P.Y. Xia, and G.X. Xiao A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo Int Immunopharmacol 8 2008 775 781
23. Y. Rosenfeld, N. Papo, and Y. Shai Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action J Biol Chem 281 2006 1636 1643
24. S. Russell, M.A. Hayes, E. Simko, and J.S. Lumsden Plasma proteomic analysis of the acute phase response of rainbow trout (Oncorhynchus mykiss) to intraperitoneal inflammation and LPS injection Dev Comp Immunol 30 2006 393 406 (Pubitemid 43003492)
25. M.G. Scott, D.J. Davidson, M.R. Gold, D. Bowdish, and R.E.W. Hancock The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses J Immunol 169 2002 3883 3891
26. S.M. Travis, N.N. Anderson, W.R. Forsyth, C. Espiritu, B.D. Conway, and E.P. Greenberg Bactericidal activity of mammalian cathelicidin-derived peptides Infect Immun 68 2000 2748 2755 (Pubitemid 30253851)
27. D. Vandamme, B. Landuyt, W. Luyten, and L. Schoofs A comprehensive summary of LL-37, the factotum human cathelicidin peptide Cell Immunol 280 2012 22 35
28. S. Wang, Y. Wang, J. Ma, Y. Ding, and S. Zhang Phosvitin plays a critical role in the immunity of zebrafish embryos via acting as a pattern recognition receptor and an antimicrobial effector J Biol Chem 286 2011 22653 22664
29. H.S. Warren Strategies for the treatment of sepsis N Engl J Med 336 1997 952 953 (Pubitemid 27137199)
30. C.A. Weiss 3rd, K.R. Wasiluk, T.A. Kellogg, and D.L. Dunn Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor Surgery 128 2000 339 344 (Pubitemid 30622503)
31. S.T. Yang, S.Y. Shin, K.S. Hahm, and J.I. Kim Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities Int J Antimicrob Agents 27 2006 325 330
32. G. Zhang, and S. Ghosh Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors J Endotoxin Res 6 2000 453 457 (Pubitemid 32409432)
33. E.J. Ziegler, C.J. Fisher Jr., C.L. Sprung, R.C. Straube, J.C. Sadoff, and G.E. Foulke Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group N Engl J Med 324 1991 429 436
34. E.J. Ziegler, J.A. McCutchan, J. Fierer, M.P. Glauser, J.C. Sadoff, and H. Douglas Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli N Engl J Med 307 1982 1225 1230 (Pubitemid 12001356)